MarginsXMarginsX
Home › Markets › Health Care › BYSI

BeyondSpring Inc. (BYSI)

BYSI trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.5788
-3.73% on the day
Market cap
$23.8M
Nano cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
-$1.0M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1677940/000117184326001908/0001171843-26-001908-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerBYSI on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2017
SEC CIK0001677940
SEC industry codePharmaceutical Preparations
Incorporated inDELAWARE

Financials · 2025

LineValue
Revenue$0
Net income-$1.0M
Operating income-$8.9M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
Cash$7.8M
Total assets$25.9M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Warning signs

Cash runway
1.9 months
$2.7M cash at June 30, 2026
Share count, 1 year
+2.0%
2025-07-25 to 2026-07-31
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
-$553K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt regarding the Company's ability to continue as a going concern."
10-Q 2026-08-14
Cash and burn$2.7M cash; operating cash flow -$4.2M a quarter.Report 2026-06-30
Shares outstanding41,119,820 (2026-07-31); 40,332,320 a year earlier.Cover page 2026-07-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-09-29
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-10-02
AuditorCBIZ CPAs P.C., Costa Mesa, California, United States; changed auditors 1 time in 24 months8-K 4.01 2025-04-11
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $553K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$0-$849K-$3.8M$2.7MNo debt tags$010-Q 2026-08-14
Q1 2026
2026-03-31
$0-$2.2M-$3.3M$4.0MNo debt tags$010-Q 2026-05-13
Q4 2025
2025-12-31
$0-$2.1M-$5.5M$7.8MNo debt tags$010-K 2026-03-25
Q3 2025
2025-09-30
$0-$1.5M-$4.2M$12.5MNo debt tags$010-Q 2025-11-12
Q2 2025
2025-06-30
$0-$1.8M-$5.9M$9.5MNo debt tags$010-Q 2026-08-14
Q1 2025
2025-03-31
$0$4.5M-$4.2M$6.5MNo debt tags$010-Q 2026-05-13
Q4 2024
2024-12-31
$0-$1.7M$982K$2.9MNo debt tags$010-K 2026-03-25
Q3 2024
2024-09-30
$0-$2.1M-$5.2M$19.3MNo debt tagsNeeds four quarters10-Q 2025-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-09-29
Latest annual report
FORM 10-K
10-K2026-03-25
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-16
Latest current report
FORM 8-K
8-K2026-11-13
Latest proxy
FORM DEFA14A
DEFA14A2026-09-03

Source: SEC EDGAR submissions feed, 266 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-4.0%
1 month-1.0%
3 months-39.7%
Year to date-63.1%
1 year-70.8%
From 52-week high-74.4%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
FLNAFilana Therapeutics Inc.$0.4700+10.56%$23.6M
GRDXGridAI Technologies Corp.$3.30-11.76%$23.5M
IXHLIncannex Healthcare Inc.$1.93-2.03%$24.2M
RNAZTransCode Therapeutics Inc.$1.35-1.46%$22.9M
IMMPImmutep Limited$3.40-2.30%$25.1M
CRVOCervoMed Inc.$1.67-1.18%$25.3M
ABVCABVC BioPharma Inc.$0.9400+3.30%$25.4M
EDSAEdesa Biotech Inc. Common Shares$1.89-2.58%$25.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier